Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2034061243;61244;61245 chr2:178590707;178590706;178590705chr2:179455434;179455433;179455432
N2AB1869956320;56321;56322 chr2:178590707;178590706;178590705chr2:179455434;179455433;179455432
N2A1777253539;53540;53541 chr2:178590707;178590706;178590705chr2:179455434;179455433;179455432
N2B1127534048;34049;34050 chr2:178590707;178590706;178590705chr2:179455434;179455433;179455432
Novex-11140034423;34424;34425 chr2:178590707;178590706;178590705chr2:179455434;179455433;179455432
Novex-21146734624;34625;34626 chr2:178590707;178590706;178590705chr2:179455434;179455433;179455432
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACA
  • RefSeq wild type template codon: TGT
  • Domain: Fn3-35
  • Domain position: 70
  • Structural Position: 103
  • Q(SASA): 0.1763
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/A rs2050022624 None 0.826 N 0.383 0.108 0.144782658237 gnomAD-3.1.2 6.58E-06 None None None None N None 0 0 0 0 0 None 0 0 0 2.07039E-04 0
T/A rs2050022624 None 0.826 N 0.383 0.108 0.144782658237 gnomAD-4.0.0 3.71994E-06 None None None None N None 0 0 None 0 0 None 0 1.64799E-04 2.54372E-06 1.09895E-05 1.602E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.0785 likely_benign 0.0864 benign -0.864 Destabilizing 0.826 D 0.383 neutral N 0.477480328 None None N
T/C 0.2935 likely_benign 0.3241 benign -0.525 Destabilizing 0.999 D 0.447 neutral None None None None N
T/D 0.3182 likely_benign 0.3392 benign -0.364 Destabilizing 0.046 N 0.173 neutral None None None None N
T/E 0.2525 likely_benign 0.2594 benign -0.289 Destabilizing 0.079 N 0.167 neutral None None None None N
T/F 0.1944 likely_benign 0.2384 benign -0.623 Destabilizing 0.997 D 0.533 neutral None None None None N
T/G 0.2459 likely_benign 0.2755 benign -1.197 Destabilizing 0.939 D 0.43 neutral None None None None N
T/H 0.2334 likely_benign 0.2709 benign -1.368 Destabilizing 0.991 D 0.524 neutral None None None None N
T/I 0.1023 likely_benign 0.1147 benign -0.042 Destabilizing 0.996 D 0.409 neutral N 0.47592289 None None N
T/K 0.2308 likely_benign 0.2335 benign -0.723 Destabilizing 0.92 D 0.381 neutral N 0.457507701 None None N
T/L 0.0804 likely_benign 0.0891 benign -0.042 Destabilizing 0.969 D 0.346 neutral None None None None N
T/M 0.0827 likely_benign 0.0925 benign 0.035 Stabilizing 0.999 D 0.436 neutral None None None None N
T/N 0.1046 likely_benign 0.1124 benign -0.847 Destabilizing 0.17 N 0.147 neutral None None None None N
T/P 0.1639 likely_benign 0.1664 benign -0.283 Destabilizing 0.996 D 0.405 neutral N 0.503781495 None None N
T/Q 0.2169 likely_benign 0.2362 benign -0.844 Destabilizing 0.939 D 0.375 neutral None None None None N
T/R 0.1915 likely_benign 0.2035 benign -0.639 Destabilizing 0.92 D 0.403 neutral N 0.471650434 None None N
T/S 0.098 likely_benign 0.1063 benign -1.133 Destabilizing 0.826 D 0.431 neutral N 0.414642358 None None N
T/V 0.095 likely_benign 0.1053 benign -0.283 Destabilizing 0.969 D 0.379 neutral None None None None N
T/W 0.4994 ambiguous 0.5706 pathogenic -0.632 Destabilizing 0.999 D 0.566 neutral None None None None N
T/Y 0.2091 likely_benign 0.2396 benign -0.374 Destabilizing 0.997 D 0.534 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.